A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected Patients
We aimed to search for laboratory predictors of critical COVID-19 in consecutive adults admitted in an academic center between 16 September 2020–20 December 2021. Patients were uniformly treated with low-molecular-weight heparin, and dexamethasone plus remdesivir when SpO2 < 94%. Among consecutive unvaccinated patients without underlying medical conditions (<i<n</i< = 241, 49 year-old median, 71% males), 22 (9.1%) developed critical disease and 2 died (0.8%). White-blood-cell counts, neutrophils, neutrophil-to-lymphocyte ratio, CRP, fibrinogen, ferritin, LDH and γ-GT at admission were each univariably associated with critical disease. ROC-defined cutoffs revealed that CRP < 61.8 mg/L, fibrinogen < 616.5 mg/dL and LDH < 380.5 U/L were each associated with critical disease development, independently of age, sex and days from symptom-onset. A score combining higher-than-cutoff CRP (0/2), LDH (0/1) and fibrinogen (0/1) predicted critical disease (AUC: 0.873, 95% CI: 0.820–0.926). This score performed well in an unselected patient cohort (<i<n</i< = 1228, 100% unvaccinated) predominantly infected by the alpha variant (AUC: 0.718, 95% CI: 0.683–0.753), as well as in a mixed cohort (<i<n</i< = 527, 65% unvaccinated) predominantly infected by the delta variant (AUC: 0.708, 95% CI: 0.656–0.760). Therefore, we propose that a combination of standard biomarkers of acute inflammatory response, cell death and hypercoagulability reflects the severity of COVID-19 per se independently of comorbidities, age and sex, being of value for risk stratification in unselected patients..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Journal of Clinical Medicine - 11(2022), 7, p 1810 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vasiliki E. Georgakopoulou [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.3390/jcm11071810 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ001236261 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ001236261 | ||
003 | DE-627 | ||
005 | 20240414120855.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm11071810 |2 doi | |
035 | |a (DE-627)DOAJ001236261 | ||
035 | |a (DE-599)DOAJ778f1a5d126c4124a4e1b09f2d0df635 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Vasiliki E. Georgakopoulou |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected Patients |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a We aimed to search for laboratory predictors of critical COVID-19 in consecutive adults admitted in an academic center between 16 September 2020–20 December 2021. Patients were uniformly treated with low-molecular-weight heparin, and dexamethasone plus remdesivir when SpO2 < 94%. Among consecutive unvaccinated patients without underlying medical conditions (<i<n</i< = 241, 49 year-old median, 71% males), 22 (9.1%) developed critical disease and 2 died (0.8%). White-blood-cell counts, neutrophils, neutrophil-to-lymphocyte ratio, CRP, fibrinogen, ferritin, LDH and γ-GT at admission were each univariably associated with critical disease. ROC-defined cutoffs revealed that CRP < 61.8 mg/L, fibrinogen < 616.5 mg/dL and LDH < 380.5 U/L were each associated with critical disease development, independently of age, sex and days from symptom-onset. A score combining higher-than-cutoff CRP (0/2), LDH (0/1) and fibrinogen (0/1) predicted critical disease (AUC: 0.873, 95% CI: 0.820–0.926). This score performed well in an unselected patient cohort (<i<n</i< = 1228, 100% unvaccinated) predominantly infected by the alpha variant (AUC: 0.718, 95% CI: 0.683–0.753), as well as in a mixed cohort (<i<n</i< = 527, 65% unvaccinated) predominantly infected by the delta variant (AUC: 0.708, 95% CI: 0.656–0.760). Therefore, we propose that a combination of standard biomarkers of acute inflammatory response, cell death and hypercoagulability reflects the severity of COVID-19 per se independently of comorbidities, age and sex, being of value for risk stratification in unselected patients. | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a comorbidities | |
650 | 4 | |a prognosis | |
650 | 4 | |a vaccination | |
650 | 4 | |a critical disease | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Nikolaos I. Vlachogiannis |e verfasserin |4 aut | |
700 | 0 | |a Dimitrios Basoulis |e verfasserin |4 aut | |
700 | 0 | |a Irene Eliadi |e verfasserin |4 aut | |
700 | 0 | |a Georgios Georgiopoulos |e verfasserin |4 aut | |
700 | 0 | |a Georgios Karamanakos |e verfasserin |4 aut | |
700 | 0 | |a Sotiria Makrodimitri |e verfasserin |4 aut | |
700 | 0 | |a Stamatia Samara |e verfasserin |4 aut | |
700 | 0 | |a Maria Triantafyllou |e verfasserin |4 aut | |
700 | 0 | |a Pantazis M. Voutsinas |e verfasserin |4 aut | |
700 | 0 | |a Fotinie Ntziora |e verfasserin |4 aut | |
700 | 0 | |a Mina Psichogiou |e verfasserin |4 aut | |
700 | 0 | |a Michael Samarkos |e verfasserin |4 aut | |
700 | 0 | |a Petros P. Sfikakis |e verfasserin |4 aut | |
700 | 0 | |a Nikolaos V. Sipsas |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Journal of Clinical Medicine |d MDPI AG, 2013 |g 11(2022), 7, p 1810 |w (DE-627)DOAJ000006793 |x 20770383 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:7, p 1810 |
856 | 4 | 0 | |u https://doi.org/10.3390/jcm11071810 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/778f1a5d126c4124a4e1b09f2d0df635 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2077-0383/11/7/1810 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2077-0383 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 7, p 1810 |